BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 37400144)

  • 1. Involvement of AKT/PI3K Pathway in Sanguinarine's Induced Apoptosis and Cell Cycle Arrest in Triple-negative Breast Cancer Cells.
    Messeha SS; Noel S; Zarmouh NO; Womble T; Latinwo LM; Soliman KFA
    Cancer Genomics Proteomics; 2023; 20(4):323-342. PubMed ID: 37400144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
    Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells.
    Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
    Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
    Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
    Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
    Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
    Xu Y; Fang R; Shao J; Cai Z
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34036307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells.
    Ahmed SA; Mendonca P; Messeha SS; Soliman KFA
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells.
    Messeha SS; Zarmouh NO; Antonie L; Soliman KFA
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
    Hong Y; Fan D
    Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy.
    Zhang S; Cui T; Duan Y; Zhang H; Wang B; Chen H; Ni J; Shen Y; Xiao-Ai Lv
    Clin Breast Cancer; 2022 Feb; 22(2):89-97. PubMed ID: 34535390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells.
    Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
    Eur J Pharmacol; 2020 Oct; 885():173419. PubMed ID: 32750370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
    Wu C; Qiu S; Liu P; Ge Y; Gao X
    J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis.
    Chen Z; Lu P; Li M; Zhang Q; He T; Gan L
    Medicine (Baltimore); 2024 Feb; 103(8):e37264. PubMed ID: 38394486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sericin inhibits MDA‑MB‑468 cell proliferation via the PI3K/Akt pathway in triple‑negative breast cancer.
    Niu L; Yang S; Zhao X; Liu X; Si L; Wei M; Liu L; Cheng L; Qiao Y; Chen Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
    Cheng W; Liu D; Guo M; Li H; Wang Q
    Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
    Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
    J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.